Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS.

Rumiantcev, Mikhail; Li, Wei Bo; Lindner, Simon; Liubchenko, Grigory; Resch, Sandra; Bartenstein, Peter; Ziegler, Sibylle I; Böning, Guido; Delker, Astrid

Estimation of relative biological effectiveness of ²²⁵Ac compared to ¹⁷⁷Lu during [²²⁵Ac]Ac-PSMA and [¹⁷⁷Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS.

Rumiantcev, Mikhail; Li, Wei Bo; Lindner, Simon; Liubchenko, Grigory; Resch, Sandra; Bartenstein, Peter; Ziegler, Sibylle I; Böning, Guido; Delker, Astrid.

Afiliação

Rumiantcev M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. mikhail.rumiantcev@med.uni-muenchen.de.
Li WB; Federal Office for Radiation Protection, Medical and Occupational Radiation Protection, Oberschleißheim, Germany.
Lindner S; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Liubchenko G; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Resch S; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Ziegler SI; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Böning G; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Delker A; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.